Subtopic Deep Dive
Uveitis Standardization and Nomenclature
Research Guide
What is Uveitis Standardization and Nomenclature?
Uveitis Standardization and Nomenclature refers to standardized classification systems and reporting criteria for uveitis, including anatomical locations, disease activity scores, and workshop consensus guidelines to ensure consistent clinical data across studies.
The First International Workshop established core nomenclature for uveitis reporting (Jabs et al., 2005, 4226 citations). These standards cover anterior, intermediate, posterior, and panuveitis classifications with grading for cell, flare, and vision. Over 10 papers in the provided list reference or build on this foundational framework.
Why It Matters
Standardized nomenclature enables comparable uveitis prevalence estimates, as in Thorne et al. (2016, 249 citations) reporting 121 cases per 100,000 adults. It improves clinical trial consistency, shown in Jaffe et al. (2016, 631 citations) VISUAL I trial using SUN criteria for adalimumab efficacy. In JIA-associated uveitis, Heiligenhaus et al. (2007, 379 citations) used standards to recommend screening modifications, reducing complications.
Key Research Challenges
Adapting Standards to Subtypes
Standardization struggles with uveitis subtypes like JIA-associated cases, where prevalence varies by subgroup (Heiligenhaus et al., 2007, 379 citations). Workshops provide anatomical bases, but activity scoring needs refinement for noninfectious uveitis (Jabs et al., 2005). Panuveitis monitoring requires new metrics like CVI (Agrawal et al., 2016, 259 citations).
Integrating with Systemic Diseases
Uveitis nomenclature must align with systemic conditions like Behçet's or ankylosing spondylitis (Rudwaleit et al., 2008, 284 citations). Standardization aids flare prevention studies but lacks unified criteria for comorbidities (Barisani-Asenbauer et al., 2012, 243 citations). Global epidemiology highlights vasculitis overlaps needing consistent reporting (Watts et al., 2021).
Quantifying Choroidal Involvement
Traditional nomenclature underrepresents choroidal changes in panuveitis, prompting CVI via OCT (Agrawal et al., 2016, 259 citations). Validating such metrics against SUN standards remains challenging for progression monitoring. Trials like VISUAL I rely on legacy grading, limiting vascular assessment (Jaffe et al., 2016).
Essential Papers
Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop
Douglas A. Jabs, Robert B. Nussenblatt, James T. Rosenbaum et al. · 2005 · American Journal of Ophthalmology · 4.2K citations
Adalimumab in Patients with Active Noninfectious Uveitis
Glenn J. Jaffe, Andrew D. Dick, Antoine P. Brézin et al. · 2016 · New England Journal of Medicine · 631 citations
In our trial, adalimumab was found to be associated with a lower risk of uveitic flare or visual impairment and with more adverse events and serious adverse events than was placebo. (Funded by AbbV...
Inflammation and its role in age-related macular degeneration
Anu Kauppinen, Jussi J. Paterno, Janusz Błasiak et al. · 2016 · Cellular and Molecular Life Sciences · 608 citations
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis
Athimalaipet V Ramanan, Andrew D. Dick, Ashley P Jones et al. · 2017 · New England Journal of Medicine · 397 citations
Adalimumab therapy controlled inflammation and was associated with a lower rate of treatment failure than placebo among children and adolescents with active JIA-associated uveitis who were taking a...
Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines
Arnd Heiligenhaus, Martina Niewerth, Gerd Ganser et al. · 2007 · Lara D. Veeken · 379 citations
The JIA subgroups markedly differ with respect to the prevalence and course of associated uveitis. Ophthalmological screening should be initiated early after arthritis onset and the intervals be re...
Global epidemiology of vasculitis
Richard A. Watts, Gülen Hatemi, Jane C. Burns et al. · 2021 · Nature Reviews Rheumatology · 302 citations
Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study
Martín Rudwaleit, E Rødevand, Peter Holck et al. · 2008 · Annals of the Rheumatic Diseases · 284 citations
Results of this prospective open-label study suggest that adalimumab had a substantial preventive effect on AU flares in patients with active AS, including patients with a recent history of AU flar...
Reading Guide
Foundational Papers
Read Jabs et al. (2005) first for core SUN nomenclature (4226 citations), then Heiligenhaus et al. (2007) for JIA applications and Rudwaleit et al. (2008) for anterior uveitis flares.
Recent Advances
Study Jaffe et al. (2016, VISUAL I adalimumab trial using standards), Agrawal et al. (2016, CVI metric), and Thorne et al. (2016, prevalence estimates).
Core Methods
Anatomical classification (anterior/intermediate/posterior/panuveitis), haze grading (0-4+), cell counts (0-4+), and emerging OCT CVI for choroidal vascularity.
How PapersFlow Helps You Research Uveitis Standardization and Nomenclature
Discover & Search
Research Agent uses searchPapers and citationGraph on 'Jabs et al. 2005' to map 4226 citing papers, revealing adaptations in Jaffe et al. (2016). exaSearch queries 'uveitis SUN criteria Behçet’s' for syndrome-specific nomenclature. findSimilarPapers expands from Heiligenhaus et al. (2007) to JIA screening mods.
Analyze & Verify
Analysis Agent applies readPaperContent to Jabs et al. (2005) abstract, verifying anatomical terms via verifyResponse (CoVe). runPythonAnalysis parses Thorne et al. (2016) prevalence data (121/100k) with pandas for statistical checks. GRADE grading assesses Jaffe et al. (2016) trial evidence as high for adalimumab.
Synthesize & Write
Synthesis Agent detects gaps in panuveitis metrics post-Jabs (2005) via contradiction flagging with Agrawal (2016) CVI. Writing Agent uses latexEditText for SUN criteria tables, latexSyncCitations for 10-paper bibliography, and latexCompile for trial reports. exportMermaid diagrams workshop consensus flows.
Use Cases
"Analyze prevalence data from uveitis standardization papers using Python"
Research Agent → searchPapers('uveitis nomenclature prevalence') → Analysis Agent → readPaperContent(Thorne 2016) → runPythonAnalysis(pandas plot 121/100k vs children 29/100k) → matplotlib prevalence chart.
"Write LaTeX review of Jabs 2005 SUN criteria for Behçet’s uveitis"
Synthesis Agent → gap detection(Jabs 2005 + Watts 2021) → Writing Agent → latexEditText(SUN table) → latexSyncCitations(Heiligenhaus 2007, Rudwaleit 2008) → latexCompile → PDF with nomenclature diagram.
"Find code for Choroidal Vascularity Index in panuveitis papers"
Research Agent → searchPapers('CVI uveitis Agrawal') → paperExtractUrls(Agrawal 2016) → paperFindGithubRepo → githubRepoInspect(OCT analysis scripts) → runPythonAnalysis(NumPy CVI computation).
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers('uveitis standardization') → citationGraph(Jabs 2005) → DeepScan 7-steps analyzes 50+ papers with GRADE on trials like Jaffe (2016). Theorizer generates nomenclature extensions for Behçet’s from Heiligenhaus (2007) + Watts (2021), outputting Mermaid subtype trees. Chain-of-Verification ensures CoVe on all prevalence claims.
Frequently Asked Questions
What is the definition of Uveitis Standardization and Nomenclature?
It encompasses standardized anatomical (anterior, intermediate, posterior, panuveitis) and activity grading (cells, flare) from the First International Workshop (Jabs et al., 2005).
What methods define uveitis nomenclature?
SUN criteria from Jabs et al. (2005) standardize reporting; CVI (Agrawal et al., 2016) adds OCT vascular metrics for panuveitis.
What are key papers on this topic?
Jabs et al. (2005, 4226 citations) foundational workshop; Heiligenhaus et al. (2007, 379 citations) JIA adaptations; Thorne et al. (2016, 249 citations) prevalence using standards.
What open problems exist?
Refining scoring for choroidal subtypes (Agrawal 2016); integrating systemic vasculitis nomenclature (Watts 2021); subtype-specific screening in JIA (Heiligenhaus 2007).
Research Ocular Diseases and Behçet’s Syndrome with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Uveitis Standardization and Nomenclature with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers